Charcot-Marie-Tooth disease and related inherited neuropathies

Medicine

Volumn 75, Issue 5, 1996, Pages 233-250

  Murakami, Tatsufumi ^a   Garcia, Carlos A ^b   Reiter, Lawrence T ^a   Lupski, James R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; CHROMOSOME 17P; DISEASE ASSOCIATION; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION; GENE REARRANGEMENT; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW;

AGE OF ONSET; AXONS; CHARCOT-MARIE-TOOTH DISEASE; CHROMOSOMES, HUMAN, PAIR 17; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE DELETION; GENE DOSAGE; GENE REARRANGEMENT; HEREDITARY MOTOR AND SENSORY NEUROPATHIES; HUMANS; MALE; MULTIGENE FAMILY; MUSCLE, SKELETAL; MYELIN P0 PROTEIN; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; POINT MUTATION; SEX FACTORS; X CHROMOSOME;

EID: 0029793042     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199609000-00001     Document Type: Review

References (186)

1. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U. Hyper-myelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nature Genet 11: 274-80, 1995.
2. Allan W. Relation of hereditary pattern to clinical severity as illustrated by peroneal atrophy. Arch Intern Med 63: 1123-1131, 1939.
3. Baechner D, Liehr T, Hameister H, Altenberger H, Grehl H, Suter U, Rautenstrauß B. Widespread expression of the peripheral myelin protein-22 gene (pmp22) in neural and non-neural tissues during murine development. J Neurosci Res 42: 733-41, 1995.
4. Ballabio A, Zoghbi HY. Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, p. 4569, 1995.
5. Behse F, Buchthal F, Carlsen F, Knappeis GG. Hereditary neuropathy with liability to pressure palsies: Electrophysiological and histopathological aspects. Brain 95: 777-94, 1972.
6. Bellone E, Mandich P, Mancardi GL, Schenone A, Uccelli A, Abbruzzese M, Sghirlanzoni A, Pareyson D, Ajmar F. Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families. J Med Genet 29: 492-3, 1992.
7. Ben Othmane K, Hentati F, Lennon F, Ben Hamida C, Blel S, Roses AD, Pericak-Vance MA, Ben Hamida M, Vance JM. Linkage of a locus (CMT4A) for autosomal recessive Charcot-Marie-Tooth disease to chromosome 8q. Hum Mol Genet 2: 1625-1628, 1993.
8. Ben Othmane K, Middleton LT, Loprest LJ, Wilkinson KM, Lennon F, Rozear MP, Stajich JM, Gaskell PC, Roses AD, Pericak-Vance MA, Vance JM. Localization of a gene (CMT2A) for autosomal domomant Charcot-Marie-Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity. Genomics 17: 370-5, 1993.
9. Berciano J, Combarros O, Calleja J, Polo JM, Leno C. The application of nerve conduction and clinical studies to genetic counseling in hereditary motor and sensory neuropathy type I. Muscle Nerve 12: 302-6, 1989.
10. Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, Chen K, Lensch MW, Chance PF, Fischbeck KH. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 262: 2039-2042, 1993.
11. Bergoffen J, Trofatter J, Pericak-Vance MA, Haines JL, Chance PF, Fischbeck KH. Linkage localization of X-linked Charcot-Marie-Tooth disease. Am J Hum Genet 52: 312-8, 1993.
12. Bird TD, Bennett RL. Why do DNA testing? Practical and ethical implications of new neurogenetic tests. Ann Neurol 38: 141-6, 1995.
13. Bird TD, Ott J, Giblett ER. Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. Am J Hum Genet 34: 388-94, 1982.
14. Blair IP, Kennerson ML, Nicholson GA. Detection of Charcot-Marie-Tooth type 1A duplication by the polymerase chain reaction. Clin Chem 41: 1105-1108, 1995.
15. Blair IP, Nash J, Gordon MJ, Nicholson GA. Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: First report of a de novo duplication with a maternal origin. Am J Hum Genet 58: 472-6, 1996.
16. Bone LJ, Dahl N, Lensch MW, Chance PF, Kelly T, Le Guern E, Magi S, Parry G, Shapiro H, Wang S, Fischbeck KH. New connexin32 mutations associated with X-linked Charcot-Maire-Tooth disease. Neurology 45: 1863-1866, 1995.
17. Bosse F, Zoidl G, Wilms S, Gillen CP, Kuhn HG, Müller HW. Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination. J Neurosci Res 37: 529-37, 1994.
18. Bradely WG, Madrid R, Thrush DC, Campbell MJ. Recurrent brachial plexus neuropathy. Brain 98: 381-98, 1975.
19. Brewerton DA, Sandifer PH, Sweetnam DR. "Idiopathic" pes cavus: An investigation into its aetiology. Br Med J 2: 659-61, 1963.
20. Brice A, Ravisé N, Stevanin G, Gugenheim M, Bouche P, Penet C, Agid Y, the French CMT Research Group. Duplication within chromosome 17p11.2 in 12 families of French ancestry with Charcot-Marie-Tooth disease type 1a. J Med Genet 29: 807-12, 1992.
21. Carango P, Funanage VL, Quirós RE, Debruyn CS, Marks HG. Overexpression of DM20 messenger RNA in two brothers with Pelizaeus-Merzbacher disease. Ann Neurol 38: 610-7, 1995.
22. Cardoso FEC, Jankovic J. Hereditary motor-sensory neuropathy and movement disorders. Muscle Nerve 16: 904-10, 1993.
23. Chance PF, Abbas N, Lensch MW, Pentao L, Roa BB, Patel PI, Lupski JR. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet 3: 223-8, 1994.
24. Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, Swanson PD, Odelberg SJ, Disteche CM, Bird TD. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72: 143-51, 1993.
25. Chance PF, Bird TD, Matsunami N, Lensch MW, Brothman AR, Feldman GM. Trisomy 17p associated with Charcot-Marie-Tooth neuropathy type 1A phenotype: Evidence for gene dosage as a mechanism in CMT1A. Neurology 42: 2295-2299, 1992.
26. Chance PF, Bird TD, O'Connell P, Lipe H, Lalouel J-M, Leppert M. Genetic linkage and heterogeneity in type I Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathy type I). Am J Hum Genet 47: 915-25, 1990.
27. Chance PF, Lensch MW, Lipe H, Brown RH Sr, Brown RH Jr, Bird TD. Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: Two distinct genetic disorders. Neurology 44: 2253-2257, 1994.
28. Chance PF, Matsunami N, Lensch W, Smith B, Bird TD. Analysis of the DNA duplication 17p11.2 in Charcot-Marie-Tooth neuropathy type 1 pedigrees: Additional evidence for a third autosomal CMT1 locus. Neurology 42: 2037-2041, 1992.
29. Charcot J-M, Marie P. Sur une forme particulaière d'atrophie musculaire progressive souvent familiale débutant par les pied et les jambes et atteignant plus tard les mains. Rev Med 6: 97-138, 1886.
30. Charnas L, Trapp B, Griffin J. Congenital absence of peripheral myelin: Abnormal Schwann cell development causes lethal arthrogryposis multiplex congenita. Neurology 38: 966-74, 1988.
31. Cremers FPM, Pfeiffer RA, van de Pol TJR, Hofker MH, Kruse TA, Wieringa B, Ropers HH. An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-q22 region. Hum Genet 77: 23-27, 1987.
32. Cudrey C, Chevillard C, Le Paslier D, Vignal A, Passage E, Fontes M. Assignment of microsatellite sequences to the region duplicated in CMT1A (17p12): A useful tool for diagnosis. J Med Genet 32: 231-3, 1995.
33. Davies DM. Recurrent peripheral-nerve palsies in a family. Lancet 2: 266-8, 1954.
34. De Jong JGY. Over families met hereditaire dispositie tot het optreden van neuritiden gecorreleered met migraine. Psychiatr Neurol Bull 50: 60-76, 1947.
35. Debruyne J, Dehaene I, Martin JJ. Hereditary pressure-sensitive neuropathy. J Neurol Sci 47: 385-94, 1980.
36. Dejerine J, Sottas J. Sur la névrite interstitielle, hypertrophique et progressive de l'enface. C R Soc Biol 45: 63-96, 1893.
37. Dyck PJ, Chance PF, Lebo R, Carney JA. Hereditary motor and sensory neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, Low PW, Poduslo JF, eds. Peripheral neuropathy. 3rd ed. Philadelphia: WB Saunders Co., p. 1094, 1993.
38. Dyck PJ, Karnes JL, Lambert EH. Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology 39: 1302-1308, 1989.
39. Dyck PJ, Kennel AJ, Magal IV, Kraybill EN. A Virginia kinship with hereditary sensory neuropathy: Peroneal muscular atrophy and pes cavus. Mayo Clin Proc 40: 685-94, 1965.
40. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 18: 603-18, 1968.
41. Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol 18: 619-25, 1968.
42. Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 10: 222-6, 1981.
43. Dyck PJ, Swanson CJ, Low PA, Bartleson JB, Lambert EH. Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc 57: 239-46, 1982.
44. Earl CJ, Fullerton PM, Wakefleld GS, Schutta HS. Hereditary neuropathy, with liability to pressure palsies. Q J Med 33: 481-98, 1964.
45. Ellis D, Malcolm S. Proteolipid protein gene dosage effect in Pelizaeus-Merzbacher disease. Nature Genet 6: 333-4, 1994.
46. England AC, Denny-Brown D. Severe sensory changes, and trophic disorders, in peroneal muscular atrophy (Charcot-Marie-Tooth type). Arch Neurol Psychiatry 67: 1-22, 1952.
47. Fairweather N, Bell C, Cochrane S, Chelly J, Wang S, Mostacciuolo ML, Monaco AP, Haites NE. Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-Tooth disease (CMTX1). Hum Mol Genet 3: 29-34, 1994.
48. Gabreëls-Festen AAWM, Gabreëls FJM, Jennekens FGI, Joosten EMG, Janssen-van Kempen TW. Autosomal recessive form of hereditary motor and sensory neuropathy type I. Neurology 42: 1755-1761, 1992.
49. Gal A, Mücke J, Theile H, Wieacker PF, Ropers H-H, Wienker TF. X-linked dominant Charcot-Marie-Tooth disease: Suggestion of linkage with a cloned DNA sequence from the proximal Xq. Hum Genet 70: 38-42, 1985.
50. Garcia CA. The clinical features of Charcot-Marie-Tooth disorders. In: Parry GJ, ed. Charcot-Marie-Tooth disorders: A handbook for primary care physicians. Upland, PA: Charcot-Marie-Tooth Association, p. 5, 1995.
51. Garcia CA, Malamut RE, England JD, Parry GS, Liu P, Lupski JR. Clinical variability in two pairs of identical twins with the Charcot-Marie-Tooth disease type 1A duplication. Neurology 45: 2090-2093, 1995.
52. Giese KP, Martini R, Lemke G, Soriano P, Schachner M. Mouse Po gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71: 565-76, 1992.
53. Gouider R, LeGuern E, Emile J, Tardieu S, Cabon F, Samid M, Weissenbach J, Agid Y, Bouche P, Brice A. Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: Two distinct clinical, electrophysiologic, and genetic entities. Neurology 44: 2250-2252, 1994.
54. Gouider R, LeGuern E, Gugenheim M, Tardieu S, Maisonobe T, Léger JM, Vallat JM, Agid Y, Bouche P, Brice A. Clinical, electrophysiologic, and molecular correlations in 13 families with hereditary neuropathy with liability to pressure palsies and a chromosome 17p11.2 deletion. Neurology 45: 2018-2023, 1995.
55. Gregory R, Thomas PK, King RHM, Hallam PLJ, Malcolm S, Hughes RAC, Harding AE. Coexistence of hereditary motor and sensory neuropathy type Ia and IgM paraproteinemic neuropathy. Ann Neurol 33: 649-52, 1993.
56. Griffin JW. Pathologic changes in Charcot-Marie-Tooth disorders. In: Parry GJ, ed. Charcot-Marie-Tooth disorders: A handbook for primary care physicians. Upland, PA: Charcot-Marie-Tooth Association, p. 29, 1995.
57. Gutmann L, Fakadej A, Riggs JE. Evolution of nerve conduction abnormalities in children with dominant hypertrophic neuropathy of the Charcot-Marie-Tooth type. Muscle Nerve 6: 515-9, 1983.
58. Guzzetta V, Santoro L, Gasparo-Rippa P, Ragno M, Vita G, Caruso G, Andria G. Charcot-Marie-Tooth disease: Molecular characterization of patients from Central and Southern Italy. Clin Genet 47: 27-32, 1995.
59. Hallam PJ, Harding AE, Berciano J, Barker DF, Malcom S. Duplication of part of chromosome 17 is commonly associated with hereditary motor and sensory neuropathy type I (Charcot-Marie-Tooth type 1). Ann Neurol 31: 570-2, 1992.
60. Haney C, Snipes J, Shooter EM, Suter U, Garcia CA, Griffin JW, Trapp BD. Ultrastructural distribution of PMP22 in Charcot-Marie-Tooth disease type 1A. J Neuropathol Exp Neurol 55: 290-9, 1996.
61. Harati Y, Butler IJ. Congenital hypomyelinating neuropathy. J Neurol Neurosurg Psychiatry 48: 1269-1276, 1985.
62. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103: 259-80, 1980.
63. Hayasaka K, Himoro M, Sato W, Takada G, Uyemura K, Shimizu N, Bird TD, Conneally PM, Chance PF. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin Po gene. Nature Genet 5: 31-34, 1993.
64. Hayasaka K, Himoro M, Sawaishi Y, Nanao K, Takahashi T, Takada G, Nicholson GA, Ouvrier RA, Tachi N. De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nature Genet 5: 266-8, 1993.
65. Hayasaka K, Ohnishi A, Takada G, Fukushima Y, Murai Y. Mutation of the myelin Po gene in Charcot-Marie-Tooth neuropathy type 1. Biochem Biophys Res Commun 194: 1317-1322, 1993.
66. Hayasaka K, Takada G, Ionasescu W. Mutation of the myelin Po gene in Charcot-Marie-Tooth neuropathy type 1B. Hum Mol Genet 2: 1369-1372, 1993.
67. Hertz JM, Børglum AD, Brandt CA, Flint T, Bisgaard C. Charcot-Marie-Tooth disease type 1A: The parental origin of a de novo 17p11.2-p12 duplication. Clin Genet 46: 291-4, 1994.
68. Himoro M, Yoshikawa H, Matsui T, Mitsui Y, Takahashi M, Kaido M, Nishimura T, Sawaishi Y, Takada G, Hayasaka K. New mutation of the myelin Po gene in a pedigree of Charcot-Marie-Tooth neuropathy type 1. Biochem Mol Biol Int 31: 169-73, 1993.
69. Holmberg BH, Holmgren G, Nelis E, Van Broeckhoven C, Westerberg B. Charcot-Marie-Tooth disease in northern Sweden: Pedigree analysis and the presence of the duplication in chromosome 17p11.2. J Med Genet 31: 435-41, 1994.
70. Hoogendijk JE, Hensels GW, Gabreëls-Festen AAWM, Gabreëls FJM, Janssen EAM, de Jonghe P, Martin J-J, Van Broeckhoven C, Valentijn LJ, Baas F, de Visser M, Bolhuis PA. De-novo mutation in hereditary motor and sensory neuropathy type I. Lancet 339: 1081-2, 1992.
71. Hoogendijk JE, Janssen EAM, Gabreëls-Festen AAWM, Hensels GW, Joosten EMG, Gabreëls FJM, Zorn I, Valentijn LJ, Baas F, Ongerboer de Visser BW, de Visser M, Bolhuis PA. Allelic heterogeneity in hereditary motor and sensory neuropathy type Ia (Charcot-Marie-Tooth disease type 1a). Neurology 43: 1010-1015, 1993.
72. Hudson LD, Puckett C, Berndt J, Chan J, Gencic S. Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder. Proc Natl Acad Sci USA 86: 8128-8131, 1989.
73. Ionasescu V, Searby C, Ionasescu R. Point mutations of the connexin32 (GJB1) gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Hum Mol Genet 3: 355-8, 1994.
74. Ionasescu W. Charcot-Marie-Tooth neuropathies: From clinical description to molecular genetics. Muscle Nerve 18: 267-75, 1995.
75. Ionasescu VV, Ionasescu R, Searby C. Screening of dominantly inherited Charcot-Marie-Tooth neuropathies. Muscle Nerve 16: 1232-1238, 1993.
76. Ionasescu VV, Ionasescu R, Searby C, Barker DF. Charcot-Marie-Tooth neuropathy type 1A with both duplication and non-duplication. Hum Mol Genet 2: 405-10, 1993.
77. Ionasescu VV, Ionasescu R, Searby C, Neahring R. Dejerine-Sottas disease with de novo dominant point mutation of the PMP22 gene. Neurology 45: 1766-1767, 1995.
78. Ionasescu VV, Trofatter J, Haines JL, Summers AM, Ionasescu R, Searby C. Heterogeneity in X-linked recessive Charcot-Marie-Tooth neuropathy. Am J Hum Genet 1075-1083, 1991.
79. Kagawa T, Ikenaka K, Inoue Y, Kuriyama S, Tsujii T, Nakao J, Nakajima K, Aruga J, Okano H, Mikoshiba K. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13: 427-42, 1994.
80. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA. Nerve conduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurology 43: 1806-1808, 1993.
81. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA. Uniform slowing of conduction velocities in Charcot-Marie-Tooth polyneuropathy type 1. Neurology 43: 2664-2667, 1993.
82. Killian JM, Kloepfer HW. Homozygous expression of a dominant gene for Charcot-Marie-Tooth neuropathy. Ann Neurol 5: 515-22, 1979.
83. Killian JM, Tiwari PS, Jacobson S, Jackson RD, Lupski JR. Longitudinal studies of the duplication form of Chracot-Marie-Tooth polyneuropathy. Muscle Nerve 19: 74-78, 1996.
84. Kimura J. Electrodiagnosis in diseases of nerve and muscle: Principles and practice. Philadelphia: F.A. Davis Co., 1989.
85. Koenig HL, Schumacher M, Ferzaz B, Do Thi AN, Ressouches A, Guennoun R, Jung-Testas I, Robel P, Akwa Y, Baulieu E-E. Progesterone synthesis and myelin formation by Schwann cells. Science 268: 1500-1503, 1995.
86. Kulkens T, Bolhuis PA, Wolterman RA, Kemp S, te Nijenhuis S, Valentijn LJ, Hensels GW, Jennekens FGI, de Visser M, Hoogendyk JE, Baas F. Deletion of the serine 34 codon from the major peripheral myelin protein Po gene in Charcot-Marie-Tooth disease type 1B. Nature Genet 35-39, 1993.
87. Kwon JM, Elliott JL, Yee W, Ivanovich J, Scavarda NJ, Moolsintong PJ, Goodfellow PJ. Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q. Am J Hum Genet 57: 853-8, 1995.
88. Latour P, Blanquet F, Nelis E, Bonnebouche C, Chapon F, Diraison P, Ollagnon E, Dautigny A, Pham-Dinh D, Chazot G, Boucherat M, Van Broeckhoven C, Vandenberghe A. Mutations in the myelin protein zero gene associated with Charcot-Marie-Tooth disease type 1B. Hum Mutat 6: 50-54, 1995.
89. Le Guern E, Gouider R, Lopes J, Abbas N, Gugenheim M, Tardieu S, Ravisé N, Léger J-M, Vallat J-M, Bouche P, Agid Y, Brice A, the French CMT Collaborative Research Group. Constant rearrangement of the CMT1A-REP sequences in HNPP patients with a deletion in chromosome 17p11.2: A study of 30 unrelated cases. Hum Mol Genet 4: 1673-1874, 1995.
90. Le Guern E, Gouider R, Ravisé N, Lopes J, Tardieu S, Gugenheim M, Abbas N, Bouche P, Agid Y, Brice A. A de novo case of hereditary neuropathy with liability to pressure palsies (HNPP) of maternal origin: A new mechanism for deletion in 17p11.2? Hum Mol Genet 5: 103-6, 1996.
91. Le Guern E, Sturtz F, Gugenheim M, Gouider R, Bonnebouche C, Ravisé N, Gonnaud P-M, Tardieu S, Bouche P, Chazot G, Agid Y, Vandenberghe A, Brice A. Detection of deletion within 17p11.2 in 7 French families with hereditary neuropathy with liability to pressure palsies (HNPP). Cytogenet Cell Genet 65: 261-4, 1994.
92. Lebo RV, Chance PF, Dyck PJ, Redila-Flores MT, Lynch ED, Golbus MS, Bird TD, King MC, Anderson LA, Hall J, Wiegant J, Jiang Z, Dazin PF, Punnett HH, Schonberg SA, Moore K, Shull MM, Gendler S, Hurko O, Lovelace RE, Latov N, Trofatter J, Conneally PM. Chromosome 1 Charcot-Marie-Tooth disease (CMT1B) locus in the Fcy receptor region. Hum Genet 88: 1-12, 1991.
93. Lebo RV, Martelli L, Su Y, Li L, Lynch E, Mansfield E, Pua K-H, Watson DF, Chueh J, Hurko O. Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A by multicolor in situ hybridization. Am J Med Genet 47: 441-50, 1993.
94. Lorenzetti D, Pareyson D, Sghirlanzoni A, Roa BB, Abbas NE, Pandolfo M, Di Donate S, Lupski JR. A 1.5-Mb deletion in 17p11.2-p12 is frequently observed in Italian families with hereditary neuropathy with liability to pressure palsies. Am J Hum Genet 56: 91-98, 1995.
95. Lupski JR. An inherited DNA rearrangement and gene dosage effect are responsible for the most common autosomal dominant peripheral neuropathy: Charcot-Marie-Tooth disease type 1A. Clin Res 40: 645-52, 1992.
96. Lupski JR. Molecular genetics of Charcot-Marie-Tooth disease and related peripheral neuropathies. In: Jameson JL, ed. Textbook of molecular medicine. Cambridge: Blackwell Scientific, 1996.
97. Lupski JR, Chance PF, Garcia CA. Inherited primary peripheral neuropathies: Molecular genetics and clinical implications of CMT1A and HNPP. JAMA 17: 2326-2330, 1993.
98. Lupski JR, Garcia CA. Molecular genetics and neuropathology of Charcot-Marie-Tooth disease type 1A. Brain Pathol 2: 337-49, 1992.
99. Lupski JR, Garcia CA, Parry GJ, Patel PI. Charcot-Marie-Tooth polyneuropathy syndrome: Clinical, electrophysiologic, and genetic aspects. In: Appel S, ed. Current neurology. Chicago: Mosby Yearbook, p. 1, 1991.
100. Lupski JR, Montes de Oca-Luna R, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA, Chakravarti A, Patel PI. DNA duplication associated with Charcot-Marie-Tooth disease type 1A Cell 66: 219-32, 1991.
101. Lupski JR, Pentao L, Williams LL, Patel PI. Stable inheritance of the CMT1A DNA duplication in two patients with CMT1 and NF1. Am J Med Genet 45: 92-96, 1993.
102. Lupski JR, Roth JR, Weinstock GM. Chromosomal duplications in bacteria, fruit flies, and humans. Am J Hum 58: 21-27, 1996.
103. Lupski JR, Wise CA, Kuwano A, Pentao L, Parke JT, Glaze DG, Ledbetter DH, Greenberg F, Patel PI. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nature Genet 1: 29-33, 1992.
104. MacMillan JC, Upadhyaya M, Harper PS. Charcot-Marie-Tooth disease type 1a (CMT1a): Evidence for trisomy of the region p11.2 of chromosome 17 in south Wales families. J Med Genet 29: 12-13, 1991.
105. Madrid R, Bradley WG. The pathology of neuropathies with focal thickening of the myelin sheath (tomaculous neuropathy): Studies on the formation of the abnormal myelin sheath. J Neurol Sci 25: 415-48, 1975.
106. Mancardi GL, Uccelli A, Bellone E, Sghirlanzoni A, Mandich P, Pareyson D, Schenone A, Abbruzzese M, Ajmar F. 17p11.2 duplication is a common finding in sporadic cases of Charcot-Marie-Tooth type 1. Eur Neurol 34: 135-9, 1994.
107. Mandich P, James R, Nassani S, Defferrari R, Bellone E, Mancardi G, Schenone A, Abbruzzese M, Rocchi M, Ajmar F, Archidiacono N. Molecular diagnosis of hereditary neuropathy with liability to pressure palsies (HNPP) by detection of 17p11.2 deletion in Italian patients. J Neurol 242: 295-8, 1995.
108. Manfioletti G, Ruaro ME, Del Sal G, Philipson L, Schneider C. A growth arrest-specific (gas) gene codes for a membrane protein. Mol Cell Biol 10: 2924-2930, 1990.
109. Mariman ECM, Gabreëls-Festen AAWM, van Beersum SEC, Jongen PJH, van de Looij E, Baas F, Bolhuis PA, Ropers HH, Gabreëls FJM. Evidence for genetic heterogeneity underlying hereditary neuropathy with liability to pressure palsies. Hum Genet 93: 151-6, 1994.
110. Mariman ECM, Gabreëls-Festen AAWM, van Beersum SEC, Valentijn LJ, Baas F, Bolhuis PA, Jongen PJH, Ropers HH, Gabreëls FJM. Prevalence of the 1.5-Mb 17p deletion in families with hereditary neuropathy with liability to pressure palsies. Ann Neurol 36: 650-5, 1994.
111. Markesbery WR, Griggs RC, Leach RP, Lapham LW. Late onset hereditary distal myopathy. Neurology 24: 127-34, 1974.
112. Martini R, Zielasek J, Toyka KV, Giese KP, Schachner M. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nature Genet 11:281-6, 1995.
113. Matise TC, Chakravarti A, Patel PI, Lupski JR, Nelis E, Timmerman V, Van Broekhoven C, Weeks DE. Detection of tandem duplications and implications for linkage analysis. Am J Hum Genet 54: 1110-1121, 1994.
114. Matsunami N, Smith B, Ballard L, Lensch MW, Robertson M, Albertsen H, Hanemann CO, Müller HW, Bird TD, White R, Chance PF. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nature Genet 1: 176-9, 1992.
115. McKusick VA. Mendelian inheritance in man: A catalog of human genes and genetic disorders. 11th ed. Baltimore: Johns Hopkins University Press, 1994.
116. Mostacciuolo ML, Schiavon F, Angelini C, Miccoli B, Piccolo F, Danieli GA. Frequency of duplication at 17p11.2 in families of northeast Italy with Charcot-Marie-Tooth disease type 1. Neuroepidemiology 14: 49-53, 1995.
117. Müller E, Mostacciuolo ML, Micaglio G, Angelini C, Danieli GA. Further evidence of a duplication in 17p11.2 in families with recurrence of HMSN Ia (Charcot-Maire-Tooth neuropathy type Ia). Hum Genet 90: 231-4, 1992.
118. Murakami T, Uchino M, Ando M. Genetic abnormalities and pathogenesis of familial amyloidotic polyneuropathy. Pathol Int 45: 1-9, 1995.
119. Navon R, Timmerman V, Löfgren A, Liang P, Nelis E, Zeitune M, Van Broeckhoven C. Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A (CMT1A) using molecular genetic techniques. Prenat Diagn 15: 633-40, 1995.
120. Nelis E, Timmerman V, De Jonghe P, Muylle L, Martin J-J, Van Broeckhoven C. Linkage and mutation analysis in an extended family with Charcot-Marie-Tooth disease type 1B. J Med Genet 31: 811-5, 1994.
121. Nelis E, Timmerman V, De Jonghe P, Van Broeckhoven C. Identification of a 5′ splice site mutation in the PMP-22 gene in autosomal dominant Charcot-Marie-Tooth disease type 1. Hum Mol Genet 3: 515-6, 1994.
122. Nelis E, Timmerman V, De Jonghe P, Vandenberghe A, Pham-Dinh D, Dautigny A, Martin J-J, Van Broeckhoven C. Rapid screening of myelin genes in CMT1 patients by SSCP analysis: Identification of new mutations and polymorphisms in the Po gene. Hum Genet 94: 653-7, 1994.
123. Nelis E, Van Broeckhoven C, and the European Collaborative Consortium. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 (CMT1) and hereditary neuropathy with liability to pressure palsies (HNPP): A European collaborative study. Eur J Hum Genet 4: 25-33, 1996.
124. Nicholson GA. Penetrance of the hereditary motor and sensory neuropathy Ia mutation: Assessment by nerve conduction studies. Neurology 41: 547-52, 1991.
125. Nicholson GA, Kennerson ML, Keats BJB, Mesterovic N, Churcher W, Barker D, Ross DA. Charcot-Marie-Tooth neuropathy type 1A mutation: Apparent crossovers with D17S122 are due to a duplication. Am J Med Genet 44: 455-60, 1992.
126. Nicholson G, Nash J. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology 43: 2558-2564, 1993.
127. Nicholson GA, Valentyn LJ, Cherryson AK, Kennerson ML, Bragg TL, DeKroon RM, Ross DA, Pollard JD, Mcleod JG, Bolhuis PA, Bass F. A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nature Genet 6: 263-66, 1994. Erratum: Nature Genet 7: 113, 1994.
128. Orth U, Fairweather N, Exler M-C, Schwinger E, Gal A. X-linked dominant Charcot-Marie-Tooth neuropathy: Valine-38-methionine substitution of connexin32. Hum Mol Genet 3: 1699-1700, 1994.
129. Palau F, Lögren A, De Jonghe P, Bort S, Nelis E, Sevilla T, Martin J-J, Vilchez J, Prieto F, Van Broeckhoven C. Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A: Unequal nonsister chromatid exchange during spermatogenesis. Hum Mol Genet 2: 2031-2035, 1993.
130. Parry GJ. Charcot-Marie-Tooth disorders: A handbook for primary care physicians. Upland, PA: Charcot-Marie-Tooth Association, 1995.
131. Patel PI, Lupski JR. Charcot-Marie-Tooth disease: A new paradigm for the mechanism of inherited disease. Trends Genet 10: 128-33, 1994.
132. Patel PI, Roa BB, Welcher AA, Schoener-Scott R, Trask BJ, Pentao L, Snipes GJ, Garcia CA, Francke U, Shooter EM, Lupski JR, Suter U. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nature Genet 1: 159-65, 1992.
133. Pentao L, Wise CA, Chinault AC, Patel PI, Lupski JR. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nature Genet 2: 292-300, 1992.
134. Priest JM, Fischbeck KH, Nouri N, Keats BJB. A locus for axonal motor-sensory neuropathy with deafness and mental retardation maps to Xq24-q26. Genomics 29: 409-12, 1995.
135. Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, Barker DF, Martin JJ, De Visser M, Bolhuis PA, Van Broeckhoven C, and the HMSN Collaborative Research Group. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT1a). Neuromusc Dis 1: 93-97, 1991.
136. Raeymaekers P, Timmerman V, Nelis E, Van Hul W, De Jonghe P, Martin J-J, Van Brockhoven C, and the HMSN Collaborative Research Group. Estimation of the size of the chromosome 17p11.2 duplication in Charcot-Marie-Tooth neuropathy type 1a (CMT1a). J Med Genet 29: 5-11, 1992.
137. Rautenstrauß B, Nelis E, Grehl H, Pfeiffer RA, Van Broeckhoven C. Identification of a de novo insertional mutation in Po in a patient with a Déjérine-Sottas syndrome (DSS) phenotype. Hum Mol Genet 3: 1701-2, 1994.
138. Readhead C, Schneider A, Griffiths I, Nave K-A. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12: 583-95, 1994.
139. Reisecker F, Leblhuber F, Lexner R, Radner G, Rosenkranz W, Wagner K. A sporadic form of hereditary neuropathy with liability to pressure palsies: Clinical, electrodiagnostic, and molecular genetic findings. Neurology 44: 753-5, 1994.
140. Reiter LT, Murakami T, Koeuth T, Pentao L, Muzny DM, Gibbs RA, Lupski JR. A recombination hot spot responsible for two inherited peripehral neuropathies is located near a mariner transposon-like element. Nature Genet 12: 288-97, 1996.
141. Reiter LT, Murakami T, Warner LE, Lupski JR. DNA rearrangements affecting dosage sensitive genes. In: McCabe ERB, ed. Mental retardation and developmental disabilities research reviews: The molecular medicine of mental retardation and developmental disabilities. New York: John Wiley and Sons (in press).
142. Roa BB, Ananth U, Garcia CA, Lupski JR. Molecular diagnosis of CMT1A and HNPP. Lab Med Int 12: 22-24, 1995.
143. Roa BB, Dyck PJ, Marks HG, Chance PF, Lupski JR. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nature Genet 5: 269-73, 1993.
144. Roa BB, Garcia CA, Pentao L, Killian JM, Trask BJ, Suter U, Snipes J, Ortiz-Lopez R, Shooter EM, Patel PI, Lupski JR. Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A. Nature Genet 5: 189-94, 1993.
145. Roa BB, Garcia CA, Suter U, Kulpa DA, Wise CA, Mueller J, Welcher AA, Snipes GJ, Shooter EM, Patel PI, Lupski JR. Charcot-Marie-Tooth disease type 1A: Association with a spontaneous point mutation in the PMP22 gene. N Engl J Med 329: 96-101, 1993.
146. Roa BB, Garcia CA, Wise CA, Anderson K, Greenberg F, Patel PI, Lupski JR. Gene dosage as a mechanism for a common autosomal dominant peripheral neuropathy: Charcot-Marie-Tooth diesease type 1A. In: Epstein CJ, ed. Phenotypic mapping of Down syndrome and other aneuploid conditions. New York: Wiley-Liss Inc., p. 187, 1993.
147. Roa BB, Greenberg F, Gunaratne P, Sauer CM, Lubinsky MS, Kozma C, Meek JM, Magenis RE, Shaffer LG, Lupski JR. Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type 1A neuropathy. Hum Genet 97:642-49, 1996.
148. Roa BB, Lupski JR. Charcot-Marie-Tooth disease and related inherited myelin disorders: Molecular genetics and implications for gene therapy. Institute of Laboratory Animal Resources (ILAR) News 36: 64-72, 1994.
149. Roa BB, Lupski JR. Molecular genetics of Charcot-Marie-Tooth neuropathy. In: Harris H, Hirschhorn K, eds. Advances in human genetics. New York: Plenum Press, p. 117, 1994.
150. Roa BB, Waner LE, Garcia CA, Russe D, Lovelace R, Chance PF, Lupski JR. Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease. Hum Mutat 7: 36-45, 1996.
151. Rosenberg RN, Iannaccone ST. The prevention of neurogenetic disease. Arch Neurol 52: 356-62, 1995.
152. Roussy G, Lévy G. Sept cas d'une maladie familiale particulière: Troubles de la marche, pieds bots et aréflexie tendineuse généraliséé avec accessoirement, légère maladressé des mains. Rev Neurol 1: 427-50, 1926.
153. Roy EP, Gutmann L, Riggs JE. Longitudinal conduction studies in hereditary motor and sensory neuropathy type 1. Muscle Nerve 12: 52-55, 1989.
154. Sabir M, Lyttle D. Pathogeneis of pes cavus in Charcot-Marie-Tooth disease. Clin Orthop 175: 173-8, 1983.
155. Schiavon F, Mostacciuolo ML, Saad F, Merlini L, Siciliano G, Angelini C, Danieli GA. Non-radioactive detection of 17p11.2 duplication in CMT1A: A study of 78 patients. J Med Genet 31: 880-3, 1994.
156. Silander K, Halonen P, Sara R, Kalimo H, Falck B, Savontaus M-L. DNA analysis in Finnish patients with hereditary neuropathy with liability to pressure palsies (HNPP). J Neurol Neurosurg Psychiatry 57: 1260-1262, 1994.
157. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 6: 98-118, 1974.
158. Snipes GJ, Suter U. Molecular anatomy and genetics of myelin proteins in the peripheral nervous system. J Anat 186: 483-94, 1995.
159. Snipes GJ, Suter U. Molecular basis of common hereditary motor and sensory neuropathies in humans and in mouse models. Brain Pathol 5: 233-47, 1995.
160. Spreyer P, Kuhn G, Hanemann CO, Gillen C, Schaal H, Kuhn R, Lemke G, Müller HW. Axon-regulated expression of a Schwann cell transcript that is homologous to a "growth arrest-specific" gene. EMBO J 10: 3661-3668, 1991.
161. Su Y, Brooks DG, Li L, Lepercq J, Trofatter JA, Ravetch JV, Lebo RV. Myelin protein zero gene mutated in Charcot-Marie-Tooth type 1B patients. Proc Natl Acad Sci USA 90: 10856-10860, 1993.
162. Suter U, Moskow JJ, Welcher AA, Snipes GJ, Kosaras B, Sidman RL, Buchberg AM, Shooter EM. A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc Natl Acad Sci USA 89: 4382-4386, 1992.
163. Suter U, Snipes GJ. Biology and genetics of hereditary motor and sensory neuropathies. Annu Rev Neurosci 18: 45-75, 1995.
164. Suter U, Snipes GJ, Schoener-Scott R, Welcher AA, Pareek S, Lupski JR, Murphy RA, Shooter EM, Patel PI. Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J Biol Chem 269: 25795-25808, 1994.
165. Suter U, Welcher AA, Snipes GJ. Progress in the molecular understanding of hereditary peripheral neuropathies reveals new insights into the biology of the peripheral nervous system. Trends Neurosci 16: 50-56, 1993.
166. Suter U, Welcher AA, Özcelik T, Snipes GJ, Kosaras B, Francke U, Billings-Gagliardi S, Sidman RL, Shooter EM. Trembler mouse carries a point mutation in a myelin gene. Nature 356: 241-4, 1992.
167. Timmerman V, Löfgren A, Le Guern E, Liang P, De Jonghe P, Martin J-J, Verhalle D, Robberecht W, Gouider R, Brice A, Van Broeckhoven C. Molecular genetic analysis of the 17p11.2 region in patients with hereditary neuropathy with liability to pressure palsies (HNPP). Hum Genet 97: 26-34, 1996.
168. Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen BW, Chen KL, Wang S, Ben Othman K, Cullen B, Leach RJ, Hanemann CO, De Jonghe P, Raeymaekers P, van Ommen G-JB, Martin J-J, Müller HW, Vance JM, Fischbeck KH, Van Broeckhoven C. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nature Genet 1: 171-5, 1992.
169. Tooth H. The peroneal type of progressive muscular atrophy. London, England: Lewis, HK, 1886.
170. Uncini A, Di Muzio A, Chiavaroli F, Gambi D, Sabatelli M, Archidiacono N, Antonacci R, Marzella R, Rocchi M. Hereditary motor and sensory neuropathy with calf hypertrophy is associated with 17p11.2 duplication. Ann Neurol 35: 552-58, 1994.
171. Uncini A, Di Guglielmo G, Di Muzio A, Gambi D, Sabatelli M, Mignogna T, Tonali P, Marzella R, Finelli P, Archidiacono N, Rocchi M. Differential electrophysiological features of neuropathies associated with 17p11.2 deletion and duplication. Muscle Nerve 18: 628-35, 1995.
172. Upadhyaya M, Roberts SH, Farnham J, MacMillan JC, Clarke A, Heath JP, Hodges ICG, Harper PS. Charcot-Marie-Tooth disease 1A (CMT1A) associated with a maternal duplication of chromosome 17p11.2-12. Hum Genet 91: 392-4, 1993.
173. Valentijn LJ, Baas F, Zorn I, Hensels GW, de Visser M, Bolhuis PA. Alternatively sized duplication in Charcot-Marie-Tooth disease type 1A. Hum Mol Genet 2: 2143-2146, 1993.
174. Valentijn LJ, Bass F, Wolterman RA, Hoogendyk JE, van den Bosch NHA, Zorn I, Gabreëls-Festen AAWM, de Visser M, Bolhuis PA. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nature Genet 2: 288-91, 1992.
175. Valentijn LJ, Bolhuis PA, Zorn I, Hoogendijk JE, van den Bosch N, Hensels GW, Stanton Jr VP, Housman DE, Fischbeck KH, Ross DA, Nicholson GA, Meershoek EJ, Dauwerse HG, van Ommen G-JB, Baas F. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nature Genet 1: 166-70, 1992.
176. Valentijn LJ, Ouvrier RA, van den Bosch NH, Bolhuis PA, Baas F, Nicholson GA. Dejerine-Sottas neuropathy is associated with a de novo PMP22 mutation. Hum Mutat 5: 76-80, 1995.
177. Vance JM, Nicholson GA, Yamaoka LH, Stajich J, Stewart CS, Speer MC, Hung W-Y, Roses AD, Barker D, Pericak-Vance MA. Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17. Exp Neurol 104: 186-9, 1989.
178. Verhalle D, Löfgren A, Nelis E, Dehaene I, Theys P, Lammens M, Dom R, Van Broeckhoven C, Robberecht W. Deletion in the CMT1A locus on chromosome 17p11.2 in hereditary neuropathy with liability to pressure palsies. Ann Neurol 35: 704-8, 1994.
179. Warner LE, Roa BB, Lupski JR. Settling the myelin protein zero question in CMT1B. Nature Genet 11: 119-20, 1995.
180. Warner LE, Roa BB, Lupski JR. Absence of PMP22 coding region mutations in CMT1A duplication patients: Further evidence supporting gene dosage as a mechanism for Charcot-Marie-Tooth disease type 1A. Hum Mutat (in press).
181. Welander L. Miopathia distalis tarda hereditaria. Acta Med Scand 141 (suppl 265): 1-124, 1951.
182. Welcher AA, Suter U, De Leon M, Snipes GJ, Shooter EM. A myelin protein is encoded by the homologue of a growth arrest-specific gene. Proc Natl Acad Sci USA 88: 7195-7199, 1991.
183. Wise CA, Garcia CA, Davis SN, Heju Z, Pentao L, Patel PI, Lupski JR. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMT1A duplication. Am J Hum Genet 53: 853-63, 1993.
184. Yoshikawa H, Dyck PJ. Uncompacted inner myelin lamellae in inherited tendency to pressure palsy. J Neuropathol Exp Neurol 50: 649-57, 1991.
185. Yoshikawa H, Nishimura T, Nakatsuji Y, Fujimura H, Himoro M, Hayasaka K, Sakoda S, Yanagihara T. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 35: 445-50, 1994.
186. Zoidl G, Blass-Kampmann S, D'Urso D, Schmalenbach C, Müller HW. Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: Modulation of cell growth. EMBO J 1122-1128, 1995.